Anti-platelet aggregation of Panax notoginseng triol saponins by regulating GP1BA for ischemic stroke therapy

Panax notoginseng triol saponins (PTS) has been used clinically for ischemic stroke therapy (IST) in China for more than 17 years due to its anti-platelet aggregation and neuro-protective effects, but its mech...

Source: Chinese Medicine - January 19, 2021 Category: Complementary Medicine Authors: Zhi-yi Xu, Yang Xu, Xiao-fang Xie, Yin Tian, Jun-hui Sui, Yong Sun, Da-sheng Lin, Xing Gao, Cheng Peng and Yu-jiang Fan Tags: Research Source Type: research